Host immunity represents a complex array of factors that evolved to provide protection against potential pathogens. While many factors regulate host immunity, glycan binding proteins (GBPs) appear to play a fundamental role in orchestrating this process. In addition, GBPs also reside at the key interface between host and pathogen. While early studies sought to understand GBP glycan binding specificity, limitations in the availability of test glycans made it difficult to elucidate a detailed understanding of glycan recognition. Recent developments in glycan microarray technology revolutionized analysis of GBP glycan interactions with significant implications in understanding the role of GBPs in host immunity. In this review, we explore different glycan microarray formats with a focus on the impact of these arrays on understanding the binding specificity and function of GBPs involved in immunity.
Introduction
Infectious disease typically represents a breach in host immunity by distinct pathogenic organisms. As individual microbes can pose unique threats, host immunity often deploys specialized factors uniquely tailored to effectively combat potential pathogens. Although many factors regulate this process, a number of glycan binding proteins (GBPs) appear to play a fundamental role in orchestrating host immunity following pathogen exposure [1, 2] . In addition, innate and acquired factors also directly engage pathogens through recognition of a diverse range of microbial glycans [1] . Pathogens themselves also utilize GBPs to facilitate host attachment, which not only contributes to host tropism, but also often reflects a fundamental virulence factor required for host invasion [1] . As a result, host and microbial glycans and the GBPs that recognize them represent a key interface in host immunity.
As GBPs regulate fundamental aspects of host immunity and also directly engage pathogens, understanding these interactions can provide important insight into host immunity and infectious disease. However, glycan ligands of GBPs represent complex post-translational modifications that often require the coordinated efforts of many different enzymes [3] . As a result, early studies designed to probe GBP glycan interactions utilized relatively simple sugar substrates [4] . While these studies provided significant insight into the general binding properties of various GBPs [4] , the potential impact of subtle glycan alterations remained enigmatic. To address this, many investigators began developing larger libraries of complex carbohydrates to provide a more detailed analysis of GBP glycan interactions [4] . In this review, we will examine the utilization of large libraries of glycans in a variety of glycan microarray formats to understand GBP glycan interactions involved in immunity.
Traditional glycan microarrays
To overcome limitations in the diversity and complexity of glycan test libraries used to evaluate GBP glycan interactions, several groups began to generate larger libraries of glycans harvested from well-characterized glycoproteins or directly synthesized using chemical synthesis or combinatorial chemoenzymatic approaches [5] [6] [7] . These libraries contain glycans representative of naturally occurring glycans, as well as uniquely modified chimeric glycans that possessed common core features with alterations not typically found in nature [5, 6, 8] . While many studies utilized a variety of approaches to interrogate these types of glycan libraries [4] , it soon became expedient to use microarray formats to accommodate a growing number of glycans and limited quantities of test GBPs available for interrogation. Furthermore, this approach requires very small amounts of test glycan, thus reducing the quantity of glycan needed to generate large glycan libraries. Using wellcharacterized glycan microarrays in this manner, careful examination of bound and unbound ligands following microarray analysis provides unique insight into the specificity of a particular GBP with detailed information regarding the impact of glycan modification on GBP recognition ( Figure 1 ) [9] .
Shotgun glycan microarrays
While well-defined glycan microarrays provide important insight regarding the specificity of GBP glycan interactions, synthetic or other limitations may reduce the overall breadth of a particular library. Furthermore, as the entire glycome of pathogens and hosts remains undefined, actual glycan ligands for a particular GBP may not be represented on a particular glycan microarray. To overcome this limitation, recent approaches generated large libraries of test glycans directly from natural sources [10 • ,11] ( Figure 2 ). While this approach does not lend itself to similar analysis of bound and unbound glycans using chemically defined targets, it does provide the potential to characterize actual glycan ligands isolated from native sources for a particular GBP [10 • ,11] . Characterization of glycan ligands using this approach also enables prioritization of native glycans for sequencing, thus facilitating a functional approach to glycomic analysis [10 • ] ( Figure 2 ). Thus, the shotgun glycan microarray represents a true functional glycomic approach where none of the glycan structures are known before their interrogation with biologically relevant GBPs [12] . Designer microarrays, on the other hand, incorporate structurally characterized naturally occurring glycans in addition to modifications of these glycans designed to elucidate detailed binding specificities of GBPs [12, 13] .
Microbial glycan microarrays
Although glycan microarrays largely based on mammalian glycans continue to provide significant insight into host GBP interactions with pathogens [13] [14] [15] [16] [17] , the glycan antigens of pathogens themselves represent a broad range of structures that incorporate diverse monosaccharides not typically found in the mammalian glycome. As a result, only limited information can be obtained following interrogation of host GBPs that recognize potential pathogens using conventional glycan microarray approaches. In order to provide a more representative repertoire of the complex glycans that decorate various pathogens, recent microarrays utilized synthetic microbial glycans or glycans harvested directly from known microbes [18] [19] [20] [21] (Figure 3 ). Utilization of microbial glycans in this way provides a unique platform of structurally diverse microbial glycans to interrogate the specificity of host factors directly involved in host pathogen interactions.
Using glycan microarrays to understand GBPs involved in immune regulation
Although glycan array analysis has been conducted on a variety of GBPs with various roles in immune regulation, array analysis of the galectin family provides a unique example of the utility of using defined and shotgun microarrays when seeking to elucidate GBP binding specificity. While early studies suggested that galectins primarily recognize β-galactoside containing glycans [4] , the impact of β-galactose or other glycan modifications on galectin recognition remained difficult to define, partly due to the apparent promiscuity of galectin family members toward a wide variety of β-galactoside containing glycans. Examination of galectins on the glycan microarray over a range of concentrations began to provide significant insight into the glycan binding preferences used by individual members of the galectin family to engage leukocytes [22] [23] [24] [25] . These results demonstrated that individual galectins display a high degree of specificity toward terminal or internal lactosamine within polylactosamine (polyLacNAc) glycans. Differences in lactosamine recognition can differentially impact the binding of individual family members following terminal sialic acid modifications with significant implications on galectin-mediated signaling [23, 24, 26] . These studies also suggested that tandem repeat galectins, such as Gal-8, might exist as a dimer, demonstrating that glycan microarrays can provide unique insight into the quaternary structures and domains of galectins responsible for signaling [23-25,27,28,29 • ]. Examination of galectin interactions with naturally occurring glycans on a shotgun glycan array extended these previous findings and demonstrated that galectins display significant preference for N glycans with extended polyLacNAc sequences [30] . Analysis of cell surface glycan binding largely corroborated these results [23, 31] .
Similar utilization of glycan microarrays provided significant insight into the binding specificity of other GBPs known to regulate host immunity, such as siglecs and C-type lectins. For example, while recognition of sialic acid became a defining feature of siglec family members, the potential impact of sialic acid presentation and modification of penultimate monosacchrides remained relatively unknown. Using the glycan microarray, Bochner and colleagues discovered that siglec 8 specifically recognizes 6′-sulfo-sLe x , among over 40 other sialylated glycans present on the microarray, which suggested that siglec 8 displays exquisite specificity for unique sialic acid presentation [32] . Similar utilization of the glycan microarray demonstrated that murine homologs of human macrophage galactose-type lectin (MGL), designated MGL1 and MGL2, display distinct binding preferences for Le x or Le a and N-acetylgalactosamine, respectively [33] . 
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Utilization of glycan microarrays to elucidate pathogen interactions with host glycans
Analysis of pathogen GBP binding specificity using glycan microarrays can also offer significant insight into pathogen interaction with host glycans. Influenza provides one of the most classic examples of viral interactions that depend on distinct host glycans for infectivity. While sialic acid recognition by the influenza hemagglutinin (HA) represents a fundamental step in virion attachment and subsequent infection, array analysis provided significant insight into the binding specificity of different strains, including the impact of HA mutations on glycan recognition [34, 35] . Although glycan microarrays with defined glycan structures can provide significant insight into the binding specificity of HA, a recent study suggested that the HA binding specificity obtained from currently defined glycan microarrays failed to accurately predict the actual glycans required for replication in the lung [36] . As a result, utilization of shotgun glycan arrays containing glycans harvested from natural sources will likely be critical in developing a complete picture of HA glycan interactions [10 • ], illustrating the utility of using combined glycan array approaches when seeking to elucidate GBP specificity.
Similar to influenza, utilization of glycan microarrays provided important information regarding the glycan binding specificities of other pathogen GBPs. For example, glycan microarray analysis identified GD1a as a glycan ligand for adenovirus 37 (Ad37), a common cause of keratoconjunctivitis [37 •• ]. A subsequent study using a similar approach identified GM2 as a key ligand for serotype 1 reovirus [38] . Similar utilization of various glycan microarrays enabled identification of glycan ligands for other viral GBPs, including SV40, parvovirus and the HA of parainfluenza [39] [40] [41] . Analogous approaches identified sialyllactosamine glycans as ligands for TgMIC1, a Toxoplasma gondi GBP adhesion protein [42] , while unique DNA conjugated glycan microarrays examined the impact of galactose or fucose presentation on Pseudomonas aeruginosa adhesion lectin 1 or IIL binding, respectively [43, 44] . While many of these studies employed recombinant GBPs, examination of intact Helicobacter pylori on glycan microarrays facilitated the identification of sialic acid binding adhesion protein, SabA [45] .
Glycan microarrays in the evaluation of host interactions with pathogens
In addition to examining pathogen interactions with host glycans, the potential specificity of host immune responses to particular glycans can also be examined using glycan microarrays. Examination of sera isolated from healthy human volunteers demonstrated that antibodies possess the ability to react with many different glycan structures [46] . However, following exposure to a microbe, very specific anti-glycan antibodies can be observed. For example, analysis of sera isolated from patients with lyme disease using shotgun glycan microarrays provided unique insight into the glycan binding specificity of sera for rare GD1b-lactone epitopes [10 • ]. Microarray studies also demonstrated that monoclonal antibodies against β-1,3 glucan possess the capacity to provide protection against fungal infection [47] .
Similarly, recent studies described the binding specificity of various neutralizing anti-HIV Microbial glycan microarrays have likewise been employed to examine serological reactivity of individuals following microbial infection using glycan antigens isolated from different species and strains of Salmonella [19] . Utilization of similar microarray approaches demonstrated that anti-dextran antibodies can display significant cross-reactivity between microbial and mammalian glycans [49] . Similar array platforms demonstrated the utility of pathogen carbohydrates in the serological diagnosis of Burkholderia pseudomallei and Burkholderia mallei infections [20] . Development of glycopeptide arrays bearing a variety of Tn antigen-possessing glycopeptides demonstrated that individuals infected with Cryptosporidium parvum developed significant and specific seroreactivity toward distinct Tn glycopeptides [21] .
Utilization of glycan microarrays not only facilitated the detection of serological specificity toward microbes, but also provided insight into the binding specificity of innate immune GBPs that directly engage pathogens. Utilization of 'designer' microarray formats provided significant insight into the minimal β-glucan polymer length needed for efficient Dectin-1 glycan engagement [13] . Similarly, mycobacterial glycan microarrays provided unique insight into the impact of mannose polymer length in the binding affinity of DC SIGN for phosphatidylinositol mannoside precursors of complex mycobacterial glycolipids [18] . Recent utilization of glycan microarrays also identified various high mannose structures as ligands for GBPs that may inhibit or facilitate HIV transmission [14, 16] .
While many innate immune GBPs primarily recognize unique microbial determinants, recent studies using glycan microarrays demonstrated that several innate immune GBPs appear to preferentially bind mammalian carbohydrate blood group antigens. As ABO(H) blood group antigen expression in blood group positive individuals prevents anti-blood group antibody formation, these results suggested that these innate immune GBPs, in particular galectin-4 (Gal-4) and galectin-8 (Gal-8), may be uniquely poised to fill this gap in adaptive immunity. Indeed, Gal-4 or Gal-8 not only specifically recognized blood group expressing microbes, but also induced direct microbial killing [29 • ]. These results provide the first example of innate immunity against molecular mimicry. Future studies using analogous approaches with highly defined glycans isolated from pathogens will not only provide unique insight into host immune recognition of pathogen glycans, but also may enable elucidation of the key binding determinants required for these interactions (Figure 3 ).
Using glycan microarrays to discover GBPs
While glycan microarrays continue to provide significant insight into the binding specificity of known GBPs, recent advances may facilitate the identification of previously unrecognized GBPs. For example, while most glycan microarray approaches examine the binding specificity of previously derivatized GBPs, recent advances may allow detection of nonderivatized proteins, such as GBPs [50 • ]. This approach would be predicted to eliminate the potential influence of derivatization on GBP glycan recognition. In addition, removing the requirement for derivatization may facilitate the detection of previously unknown GBPs isolated from various cellular sources following glycan microarray analysis, followed by utilizing this information to isolate and characterize bound GBPs.
Conclusions
Given the involvement of GBPs in the regulation of host immunity and facilitation of host pathogen interactions, understanding GBP glycan specificity represents a fundamental step in understanding immunity. Before the advent of glycan microarrays, work by many investigators identified and characterized salient features of many GBPs. However, the development and utilization of glycan microarrays provides unprecedented ability to understand the complexity of GBP binding specificity and function. Expansion of existing glycan microarray formats and development of novel technologies will continue to increase our understanding of GBP function, with significant insight into host immunity. Using shotgun glycan microarrays to identify native glycan ligands for GBPs. Glycans released from natural sources, such as red blood cells or neutrophils shown in the schematic, are derivatized with a functional linker, subjected to multidimensional chromatography and printed in a microarray format. Following interrogation of the library with GBP, glycan fractions isolated following multidimensional chromatography that correspond to GBP bound ligands are subjected to mass spec glycan sequencing to identify native glycans recognized by GBP.
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Author Manuscript Author Manuscript Using microbial glycans to examine host pathogen interactions. Glycans, in particular lipopolysaccharide O antigens, released from well-characterized microbes, undergo derivatization and printing in a microarray format. GBPs with putative pathogen recognition activity or sera are incubated with the microarray to examine potential interactions with microbial glycans. Positive interactions are confirmed by examining GBP or sera with intact microbe.
